ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Renal dysfunction"

  • 2021 American Transplant Congress

    Transplant Center Volume in High-risk Recipient Association with Graft and Patient Survival

    M. A. Merzkani, H. Murad, M. Mattu, S. Husami, M. Wang, V. Hu, S. Chang, T. Alhamad

    Transplant, Washington University, Saint Louis, MO

    *Purpose: Evaluation of high-risk recipients in transplant centers involves an intensive multidisciplinary medical evaluation and requires extensive coordination amongst various teams to follow-up on these…
  • 2021 American Transplant Congress

    Combined Liver-Kidney Transplantation in Adults With End-Stage Liver Disease: Risk Factors in Patients with Chronic Kidney Disease Stages 3-5, Not on Maintenance Dialysis

    A. Santos, E. Bueno, M. Leghrouz

    University of Florida, Gainesville, FL

    *Purpose: We aimed to identify the risk factors for combined liver-kidney transplantation (CLKT) vs. liver transplantation alone (LTA) in end stage liver disease (ESLD) patients…
  • 2021 American Transplant Congress

    Chances of Renal Recovery in Liver Only Transplant Recipients Who Were Eligible for Simultaneous Liver-Kidney Transplant

    J. Cui1, A. Spann2, A. Shingina2, H. M. Schaefer3, J. C. Slaughter4, S. Alexopoulos5, M. Izzy2

    1Internal Medicine, Vanderbilt University Medical Center, Nashville, TN, 2Gastroenterology, Hepatology, and Nutrition, Vanderbilt University Medical Center, Nashville, TN, 3Nephrology, Vanderbilt University Medical Center, Nashville, TN, 4Biostatistics, Vanderbilt University Medical Center, Nashville, TN, 5Hepatobiliary Surgery and Liver Transplantation, Vanderbilt University Medical Center, Nashville, TN

    *Purpose: Progressive decline in renal function is common among patients with end-stage liver disease. Liver transplant (LT) candidates can often develop severely impaired renal function…
  • 2021 American Transplant Congress

    Temporal Changes in Renal Function Predict Waitlist Death or Deterioration in Pediatric Liver Transplantation

    N. Thalji, L. Thalji, S. Ibrahim, T. Diwan, P. Kamath, J. Heimbach

    Mayo Clinic Rochester, Minnesota, Rochester, MN

    *Purpose: Renal dysfunction at the time of listing predicts inferior waitlist outcomes in pediatric liver transplant candidates, independent of the Pediatric End-Stage Liver Disease (PELD)…
  • 2021 American Transplant Congress

    Therapeutic Enoxaparin Dosing in Lung Transplant Recipients

    S. Finder, M. Morrison, K. B. Harrison, S. A. Heeney

    Vanderbilt University Medical Center, Nashville, TN

    *Purpose: Enoxaparin 1 mg/kg subcutaneously every 12 hours for therapeutic anticoagulation is known to increase rates of supratherapeutic anti-Xa levels in lung transplant recipients (LTRs).…
  • 2021 American Transplant Congress

    Assessing the Impact of Acute Major Adverse Kidney Events on Clinical Outcomes in Heart Transplant Recipients

    J. E. Kelly1, C. Perez1, D. Taber1, R. J. Tedford2, B. McMahon2, S. Alzaidi1, H. B. Meadows1

    1Pharmacy, MUSC Health, Charleston, SC, 2Medicine, MUSC Health, Charleston, SC

    *Purpose: The purpose of this study was to elucidate contributors to the Major Adverse Kidney Events at 30 days (MAKE-30) outcome in heart transplant recipients…
  • 2021 American Transplant Congress

    Pre Transplant Estimated Glomerular Filtration Rate and Other Predictors of Mortality and End Stage Kidney Disease After Lung Transplantation

    A. Kumar1, L. N. Bonnell2, C. Thomas3

    1Internal Medicine, University of Vermont, Burlington, VT, 2Department of General Internal Medicine Research, University of Vermont, Burlington, VT, 3Internal Medicine, University of Iowa, Iowa City, IA

    *Purpose: Lung transplantation is an established treatment for end stage lung disease and as survival has improved, chronic kidney disease (CKD) has become a common…
  • 2021 American Transplant Congress

    The Trifecta Study: Calibrating Circulating Donor-Derived Cell-Free DNA at the Time of Indication Biopsies Against the Molecular Phenotype of the Biopsy Reveals a Prominent Association with NK Cell Genes

    P. Halloran1, Z. Demko2, A. Prewett2, J. Reeve1, P. Billings2

    1Alberta Transplant Applied Genomics Centre, Edmonton, AB, Canada, 2Natera Inc., San Carlos, CA

    *Purpose: The international, multicenter, prospective Trifecta study was designed to calibrate dd-cfDNA% measurements in blood at the time of indication biopsy against the molecular characteristics…
  • 2020 American Transplant Congress

    Serum Cystatin C Predicts Kidney-Related Outcomes and Transplant-Free Survival in Patients with End-Stage Liver Disease and Low Body Mass Index

    N. Shankar1, M. Garcia Saenz de Sicilia2, A. Duarte-Rojo3, S. K. Asrani4, J. F. Trotter4, G. B. Klintmalm4, B. V. Fischbach5, S. A. Gonzalez5

    1Internal Medicine, Baylor Scott & White University Medical Center, Dallas, TX, 2University of Arkansas for Medical Sciences, Little Rock, AR, 3Department of Medicine, Division of Gastroenterology, Hepatology, and Nutrition, Center for Liver Diseases, Pittsburgh Liver Research Center, University of Pittsburgh Medical Center, Pittsburgh, PA, 4Baylor Simmons Transplant Institute, Dallas, TX, 5Baylor Simmons Transplant Institute, Fort Worth, TX

    *Purpose: Liver transplant (LT) candidates with sarcopenia are disadvantaged by creatinine-based assessment of renal function as creatinine overestimates glomerular filtration rate (GFR). Low body mass…
  • 2020 American Transplant Congress

    Post-Transplant Renal Function in ACLF Patients Based on Pre-Transplant Severity of Renal Dysfunction without Kidney Transplant

    M. Yazawa1, B. Maliakkal1, S. Nair1, Y. Jiang2, P. S. Podila3, U. A. Agbim1, S. Karri4, S. D. Khan5, D. Maluf1, J. D. Eason1, M. Z. Molnar1, S. K. Satapathy6

    1James D. Eason Transplant Institute, Methodist University Hospital, Memphis, TN, 2Division of Epidemiology, Biostatistics, and Environmental Health, The University of Memphis, Memphis, TN, 3Faith & Health Division, Methodist Le Bonheur Healthcare, Memphis, TN, 4Department of Medicine, University of Tennessee Health Science Center, Memphis, TN, 5Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, NY, 6Sandra Atlas Bass Center for Liver Diseases & Transplantation, Department of Medicine, Northshore University Hospital/Northwell Health, Manhasset, NY

    *Purpose: It is unknown whether severity of renal dysfunction in ACLF patients impacts outcome of ACLF patients compared to those without ACLF.*Methods: In a single…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • …
  • 17
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences